Archive | December, 2012

The FDA and the Ambiguity of its Actos Bladder Cancer Warning

December 28, 2012  |   Posted by :   |   Actos Attorney   |   0 Comments

Lawyers and Settlements recently published an interesting editorial about the ambiguity of the FDA’s language in warning about the bladder risk associated with Actos. To break it down, the Food and Drug Administration (FDA) issued a safety announcement in June of 2011, warning of a possible link between Actos and bladder cancer. The controversy lies […]

Read More »

New Actos Lawsuit Filed by Bladder Cancer Patient

December 13, 2012  |   Posted by :   |   Actos Attorney   |   0 Comments

The Southern California Actos lawyers at Nadrich & Cohen are actively working with patients who have suffered severe side effects from the diabetes drug Actos. Bladder cancer is the most serious, potentially fatal, side effect associated with the drug, and Nadrich & Cohen has been investigated the link as well as monitoring the pending lawsuits […]

Read More »

Actos Sales Fall 46 Percent as Lawsuits Mount

December 11, 2012  |   Posted by :   |   Actos Attorney   |   0 Comments

The California Actos attorneys at Nadrich & Cohen have long been committed to defending individuals who have fallen victim to the sometimes devastating side effects of Actos. As part of that mission, we devote a great deal of time to researching and investigating the latest developments in Actos research as well as Actos lawsuits and […]

Read More »